# MetAbolism vaRiability of VEnLafaxine

> **NCT02590185** · NA · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 205 (estimated)

## Conditions studied

- Major Depressive Disorders

## Interventions

- **DRUG:** cocktail probe drugs

## Key facts

- **NCT ID:** NCT02590185
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12
- **Primary completion:** 2019-12
- **Final completion:** 2020-04
- **Target enrollment:** 205 (ESTIMATED)
- **Last updated:** 2019-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02590185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02590185, "MetAbolism vaRiability of VEnLafaxine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02590185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*